Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,502 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05763927 | Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT | unknown | Phase 2 | 44 | West China HospitalOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT05597384 |
| Assessment of Autologous Blood Marker Localization in Laparoscopic Colorectal Cancer Surgery(ABILITY) |
| unknown |
| N/A |
| 220 |
| Shanghai East HospitalOTHER |
| 1 |
| Mar 8, 2023 |
| clinicaltrials |
| NCT05754060 | Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients(RIVAGE) | unknown | — | 200 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Mar 8, 2023 | clinicaltrials |
| NCT05423964 | Impact of AI on Trainee ADR | unknown | N/A | 25 | University of Southern CaliforniaOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT05755685 | Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial | unknown | Phase 2 | 10 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT03173001 | Possible Association of Intestinal Helminths and Protozoa With Colorectal Cancer Pathogenesis | unknown | — | 500 | Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanOTHER_GOV | 0 | Mar 3, 2023 | clinicaltrials |
| NCT04970316 | Late Organ Specific Adverse Effects hiPec or pElvic eXenteration(LOSAPEX) | unknown | — | 225 | University of AarhusOTHER | 2 | Feb 28, 2023 | clinicaltrials |
| NCT05201612 | Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC).(PEMBROLA) | unknown | Phase 2 | 40 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Feb 24, 2023 | clinicaltrials |
| NCT05740267 | Natural Orifice Specimen Extraction Surgery for Colorectal Cancer(NOSE) | unknown | N/A | 318 | Chang Gung Memorial HospitalOTHER | 0 | Feb 23, 2023 | clinicaltrials |
| NCT05732493 | Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)(TORCH-C) | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 0 | Feb 17, 2023 | clinicaltrials |
| NCT05731336 | A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan. | unknown | — | 500 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2023 | clinicaltrials |
| NCT05167448 | A Study of ES104 in Patients With Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 58 | Elpiscience (Suzhou) Biopharma, Ltd.INDUSTRY | 1 | Feb 15, 2023 | clinicaltrials |
| NCT05721872 | Efficacy, Tolerability and Safety of Intravenous D-VC With ATO in Patients With Advanced/Metastatic Colorectal Cancer | unknown | Phase 1 / Phase 2 | 38 | Nazarbayev UniversityOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT03320317 | Breakthrough Improvement Collaborative for ColoRectal Cancer (BIC4CRC)(BIC4CRC) | unknown | — | 950 | KU LeuvenOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | unknown | N/A | 300 | China Medical University HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05714475 | Pancreas Resection for Colorectal Metastasis: Retrospective Study | unknown | — | 15 | Ospedale Generale Di Zona Moriggia-PelasciniOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05185557 | BRIANSTORM - Early Identification of Patients With Brain Metastases | unknown | — | 50 | Aarhus University HospitalOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT05684211 | A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer | unknown | Phase 2 | 84 | Shanghai Celfuture Biotech Co., Ltd.INDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05453825 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | unknown | Phase 2 | 180 | OncXerna Theraputics, Inc.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05698082 | FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues | unknown | Phase 2 / Phase 3 | 120 | xiaoliang HuangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05693519 | GastroIntestinal Cancer in Children and Adolescents(GICCA) | unknown | — | 2,500 | Paul G. Kemps, MDOTHER | 1 | Jan 23, 2023 | clinicaltrials |
| NCT05523271 | A Multi Center Study Comparing the Efficacy of CAD EYE and the Standard of Care (White Light ) | unknown | N/A | 1,000 | Theodor Bilharz Research InstituteOTHER | 1 | Jan 19, 2023 | clinicaltrials |
| NCT05688033 | Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During Chemoradiotherapy | unknown | N/A | 200 | Fudan UniversityOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT05685680 | Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcimoma | unknown | N/A | 50 | Sohag UniversityOTHER | 1 | Jan 17, 2023 | clinicaltrials |
| NCT05683795 | PelvEx - Beating the Empty Pelvis Syndrome | unknown | — | 150 | University of SouthamptonOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT05682898 | Perioperative Management of Colorectal Cancer Patients Infected With COVID-19: a Multicenter Prospective Cohort Study. | unknown | — | 300 | Changhai HospitalOTHER | 0 | Jan 12, 2023 | clinicaltrials |
| NCT05314309 | Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening(mtFIT) | unknown | — | 14,712 | The Netherlands Cancer InstituteOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT04822506 | PEA Promote Gastrointestinal Function Recovered After Colorectal Cancer Operation | unknown | N/A | 30 | Shanghai Yueyang Integrated Medicine HospitalOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT05659290 | Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer | unknown | Phase 2 | 40 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 6, 2023 | clinicaltrials |
| NCT05664607 | Sarcopenia and Multimodal Rehabilitation on the Prognosis of Rectal Cancer Patients Receiving CCRT | unknown | N/A | 100 | Chang Gung Memorial HospitalOTHER | 1 | Dec 29, 2022 | clinicaltrials |
| NCT03088150 | COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation(COLLISION) | unknown | N/A | 618 | Amsterdam UMC, location VUmcOTHER | 1 | Dec 20, 2022 | clinicaltrials |
| NCT05651971 | The Anatomical Localization of the Inferior Mesenteric Artery in Relation to the Left Colonic Artery | unknown | — | 120 | Tang-Du HospitalOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT05645094 | Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer | unknown | — | 38 | Fudan UniversityOTHER | 0 | Dec 13, 2022 | clinicaltrials |
| NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer(NeoFox) | unknown | Phase 2 | 100 | WntResearch ABINDUSTRY | 1 | Dec 9, 2022 | clinicaltrials |
| NCT05640726 | The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy | unknown | Phase 2 | 30 | Fujian Cancer HospitalOTHER_GOV | 0 | Dec 7, 2022 | clinicaltrials |
| NCT05638243 | Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program(METHOD-3) | unknown | — | 10,000 | Fudan UniversityOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05634590 | The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer | unknown | Phase 2 | 68 | Fudan UniversityOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05635149 | Predictive Factors for Outcomes of Fruquintinib Plus Immunotherapy in Colorectal Cancer | unknown | — | 100 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05635630 | Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention | unknown | N/A | 110 | Fudan UniversityOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT04991090 | Management of LLN Metastasis in Locally Advanced Rectal Cancer: A Prospective Radiation Dose Escalation Study | unknown | N/A | 78 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Nov 23, 2022 | clinicaltrials |
| NCT05359406 | A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis(Miracle-2) | unknown | Phase 2 | 51 | LI XIN-XIANGOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT00986661 | A Study to Assess PV-10 Chemoablation of Cancer of the Liver | unknown | Phase 1 | 78 | Provectus Biopharmaceuticals, Inc.INDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05336643 | Radioisotope and Fluorescence Guidance in Rectal Cancer | unknown | N/A | 10 | University College, LondonOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05601388 | Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study | unknown | — | 60 | Sohag UniversityOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05446558 | Long-term Results in Intracorporeal Versus Extracorporeal Anastomosis in Laparoscopic Right Colectomy | unknown | N/A | 140 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT04278274 | Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer(MR-AI-pCR) | unknown | — | 205 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05587452 | Early Screening of Colorectal Cancer Based on Plasma Multi-omics Combining With Artificial Intelligence(RECOMMEND) | unknown | — | 950 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Oct 24, 2022 | clinicaltrials |
| NCT02633098 | A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal Cancer(NeoART) | unknown | Phase 2 | 200 | St George's, University of LondonOTHER | 1 | Oct 12, 2022 | clinicaltrials |
| NCT05575635 | Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC | unknown | Phase 2 | 40 | Henan Provincial People's HospitalOTHER | 0 | Oct 12, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Mar 10, 2023source: clinicaltrials